X

Thank you for sharing!

Your article was successfully shared with the contacts you provided.
According to CVS finance chief Dave Denton, although the present ding to the company’s bottom line comes from generics, in the long run they could actually be more profitable. (Photo: Shutterstock)

It may not feel that way to patients, but the meteoric rise in prices for drugs has slowed, causing both CVS Health and Walgreens Boots Alliance to report that pharmacy revenues are suffering as brand-name drug prices have come under pressure—both from generic substitutes and from slowing price inflation.

BenefitsPRO

Don’t miss crucial news and insights you need to navigate the shifting employee benefits industry. Join BenefitsPRO.com now!

  • Unlimited access to BenefitsPRO.com - your roadmap to thriving in a disrupted environment
  • Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
  • Exclusive discounts on BenefitsPRO.com and ALM events.

Already have an account? Sign In Now

Copyright © 2018 ALM Media Properties, LLC. All Rights Reserved.